Health Care Costs
People want to know that they can afford the care they receive and won’t have to choose between their health and potential bankruptcy.
See why we’ve made health care cost a priority.
-
November 1, 2018Health Care Costs
Health Care Affordability: The View from the Kitchen Table
A new brief released today with our research partner Penn LDI discusses different ways to define health care affordability.
-
November 1, 2018Health Care Costs, News & Updates, Resources
What is “Affordable” Health Care?
“Affordability” of health care is a common concern, but the term is rarely defined. This brief considers the different types of affordability and reviews a range of measures that capture the cost burden for different types of individuals and families. It also identifies key issues policymakers should consider to transform affordability into a policy aim.
-
October 31, 2018Health Care Costs, News & Updates, Resources, State Efforts
Prescription Drug Prices: Problems, Solutions, and What States Can Do
The price of prescription drugs has increasingly been a topic of public concern over the last several years. Americans believe that Congress and the President are not doing enough about the problem. This brief identifies drivers of rising prescription drug costs and reviews ways that states can address them.
-
May 9, 2018Federal Efforts, Health Care Costs, News & Updates
President Could Clear The Way For States To Bring Down Costs Of Prescription Drugs
In President Trump’s upcoming speech, we will be looking for two goals related to bringing down the cost of prescription drugs. There are several approaches the administration can take, including regulatory changes that empower states to take action. We will be watching to see what course the Administration decides to set.
-
April 27, 2018Health Care Costs, News & Updates, State Efforts
Utahns Want To Help Their Neighbors
First stop—Utah! USofCare listened to Utahns and found that health care is too expensive. We met with health care stakeholders, providers, policymakers, industry leaders, researchers, consumers, and patient advocates. While the issues, policies, and emotions involved are complicated, there is a willingness to work together to make it happen.